Clinical Trials Endpoints

Response-Based Imaging Endpoints for Recurrent Glioblastoma Clinical Trials

Principal Investigators: Benjamin M. Ellingson, Ph.D., Patrick Wen, M.D., and Timothy F. Cloughesy, M.D.

Institute: University of California, Los Angeles and Dana-Farber Cancer Institute

Initiative: Clinical Trials Endpoints

Location: Los Angeles, CA and Boston, MA

Principal Investigators: Benjamin M. Ellingson, Ph.D., Patrick Wen, M.D., and Timothy F. Cloughesy, M.D.

Institute: University of California, Los Angeles and Dana-Farber Cancer Institute

Initiative: Clinical Trials Endpoints

Location: Los Angeles, CA and Boston, MA

Share